This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,119.08 award is for the delivery of 100 units of the prescription drug Vyvanse 40 mg capsules. The order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a wide range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities. This particular delivery order does not have a set-aside designation. DMS Pharmaceutical Group has demonstrated its capability to fulfill federal pharmaceutical contracts and is a key supplier in the DLA's medical supply chain.
Generated 2/13/25, 9:12 AM